Inside this issueCover storiesMaking a major impact in ScienceNeuroscientists target disorders of the brain and spinal cordBanner year for Yale as six on faculty join Institute of MedicinePartnershipsNew collaboration with museum aims to improve science literacyYale, VA supporting troops on the home frontUnlikely allies, common goals in fight against obesityMedical school welcomes first Gilliam FellowsGrants & contractsPeopleLifelines: Edward Chu, moving cancer drugs into the clinicGraduate council bestows top honor on residency deanL. Veronica Lee champions prevention and women’s cardiovascular healthCell biologist Mellman elected to European academyAlumnus receives Yale Medal for his decades of serviceOut & aboutScienceAdvances: Restoring flexibility to heal broken brains | Mad cow’s small impact explained?HealthAdvances: Take sleep apnea seriously, says study | Cool therapy helps after troubled births 
Download this whole issue as a PDF file |
|
Cell biologist Mellman elected to European academy
Ira Mellman, Ph.D., chair and Sterling Professor of Cell Biology, is one of three American scientists elected as foreign members of the European Molecular Biology Organization (EMBO) at the organization’s annual meeting in Warsaw in October. Membership in EMBO is a life-long honor and scientists are elected on the basis of proven excellence in research. Among the organization’s members are some of Europe’s leading researchers, including 38 Nobel Prize winners. EMBO was established in 1964 to create a central molecular biology laboratory and to build a network that would enhance interactions among European laboratories. Currently there are more than 1,200 EMBO members in Europe, and only 60 investigators outside of Europe have been named as associate members. Mellman uses a combination of biochemical, genetic and imaging methods to understand complex functions of cell biology, especially in the immune system. Another area of his research involves the molecular mechanisms that sort, target and transport cell membrane components to appropriate locations in different types of cells. After receiving his undergraduate degree at Oberlin College, Mellman earned his doctorate in genetics from Yale in 1978. He began his academic career as a postdoctoral fellow and an assistant professor at Rockefeller University and then joined the Yale faculty in 1981. From 1997 to 2001 Mellman served as founding director of Yale’s Combined Program in Biological and Biomedical Sciences, which united all the disparate department-based graduate programs at the School of Medicine and the main Yale campus. Mellman, who holds a joint appointment in the Department of Immunobiology, is editor-in-chief of The Journal of Cell Biology and is on the editorial boards of Cell and The Journal of Experimental Medicine. He is an affiliate member of the Ludwig Institute for Cancer Research and was named scientific director of the Yale Cancer Center in 2003. He holds a senior fellowship at Lincoln College, University of Oxford, where he served as Newton-Abraham Professor. Mellman is also a fellow of the American Academy of Arts and Sciences; a member of numerous advisory boards in the public and private sectors in the U.S., Europe and Australia; the recipient of an NIH MERIT award and the Yale Science and Engineering Society Medal. Mellman has delivered endowed lectures throughout the world, including the NIH Director’s Lecture.
| ||||
Medicine@Yale publication
|
January/February 2006 Volume 2 Issue 1
|
|
|
